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Abstract Metabolic phenotyping, or metabotyping, is increas-
ingly being used as a probe in functional genomics studies.
However, such pro¢ling is subject to intrinsic physiological var-
iation found in all animal populations. Using a nuclear magnetic
resonance-based metabonomic approach, we show that diurnal
variations in metabolism can obscure the interpretation of
strain-related metabolic di¡erences in two phenotypically nor-
mal mouse strains (C57BL10J and Alpk:ApfCD). To overcome
this problem, diurnal-related metabolic variation was removed
from these spectral data by application of orthogonal signal
correction (OSC), a data ¢ltering method. Interpretation of
the removed orthogonal variation indicated that diurnal-related
variation had been removed and that the AM samples contained
higher levels of creatine, hippurate, trimethylamine, succinate,
citrate and 2-oxo-glutarate and lower levels of taurine, tri-
methylamine-N-oxide, spermine and 3-hydroxy-iso-valerate
relative to the PM samples. We propose OSC will have great
potential removing confounding variation obscuring subtle
changes in metabolism in functional genomic studies and will
be of bene¢t to optimising interpretation of proteomic and ge-
nomic datasets.
6 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Functional genomic studies o¡er a holistic approach to
studying biological systems by expanding the investigation
from studying single genes or proteins to studying all genes
or proteins at once in a systematic fashion [1]. In order to
understand fully the biological function of particular genes it
is necessary to correctly place genetic information in the con-
text of biochemical activity at the cellular and whole organism
level and metabolic phenotyping, or metabotyping, is increas-
ingly being used as a probe in functional genomics studies [2].
Nuclear magnetic resonance (NMR)-based metabonomic
approaches have been developed to aid the understanding of
pathophysiological and toxicological processes in which time-
related metabolic events in vivo are interrogated using chemo-
metric methods [2]. Metabonomics thus represents a systems
approach to understanding metabolic variation in complex
multicellular organisms. Changes in metabolism are observ-
able in NMR spectral pro¢les of bio£uids or tissues and these
data are re£ective of the metabolic status of an organism [3].
Multivariate statistical methods are employed to enhance in-
terpretation of these complex spectral data. In principle, me-
tabonomic technologies can be extended to interpretation of
genetic modi¢cations in relation to physiological processes
and we have recently demonstrated this potential by charac-
terising metabolic di¡erences in mouse models [4,5].
Interpretation of models of disease or toxicity in metabo-
nomic studies may be confounded by variation contained
within the NMR spectral data that is not related to the hy-
potheses under test. For example, physiological factors can
markedly a¡ect the metabolic composition of biological £uids
and tissues and normal physiological variation can obscure
the metabolic information that relates to the disease processes
under study. Such factors include dietary variation [6], exer-
cise and physical activity [7], normally regulated diurnal cycles
[8], estrus or menstrual cycle-related processes [8], genetic
drift, strain and species di¡erences [6,9]. Similarly, unrelated
biochemical consequences arising from gene insertion or dele-
tion in the development of transgenic models may obscure the
understanding of the physiological consequences relating to
the disease or toxicity processes under investigation. In such
cases, methods are required that can remove and minimise
interference from unrelated metabolic variation. Ideally, these
methods should enable interpretation of unrelated metabolic
variation. For example, it may be desirable to characterise the
metabolic e¡ects resulting from unwitting interventions during
the development of transgenic models.
In this study, we show the bene¢ts of pre-¢ltering data by
orthogonal signal correction (OSC) for the removal and in-
vestigation of non-correlated variation contained within spec-
tral data in NMR-based metabonomic studies. OSC was orig-
inally applied to the removal of unwanted variation from
near-infrared spectral data [10,11] although it has also found
applications on data generated by X-ray powder di¡raction
[12], £uorescence spectroscopy [13] and 13C cross-polarisation/
magic angle spinning NMR spectroscopy [14]. We report how
variation relating to diurnal cycles obscures the interpretation
of strain-related metabolic di¡erences in the phenotypically
normal C57BL10J and Alpk:ApfCD mouse strains and dem-
onstrate how OSC can eliminate this non-correlated variation
by selectively removing and identifying the metabolic changes
relating to diurnal and strain-related variation in 1H NMR
spectral data. OSC and related methods may also be applied
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to other types of multivariate data sets, such as those gener-
ated by transcriptomic and proteomic methods, and hence is
likely to be a widely applicable functional genomic tool.
2. Materials and methods
2.1. Animal handling and collection of urine for 1H NMR spectroscopy
Animal handling of male C57BLl0J and Alpk:ApfCD mice, sample
collection and storage followed previously reported procedures [4].
The possible loss of amines (due to their volatility) was minimised
by immediate collection of urine into Eppendorf containers, which
were then sealed and immediately frozen. Urine samples were ob-
tained from 8 week old C57BL10J mice at AM (collected between
9:00 and 10:00, n=20) and PM (collected between 13:30 and
14:30, n=20) time-points and Alpk:ApfCD mice at AM (collected
between 9:00 and 10:00, n=15) and PM (collected between 13:30
and 14:30, n=15) time-points by minimal manipulation of the lower
abdomen.
2.2. Sample preparation and 1H NMR spectroscopy of whole mouse
urine
Samples were randomly selected for sample preparation and 1H
NMR acquisition. Due to the small volume mouse urine collected
(typically 100 Wl) only deuterated solvents were added during sample
preparation, thus maximising NMR sensitivity. The collected urine
volumes were highly variable (40^340 Wl range); deuterium oxide
(D2O) was added to each sample to make the urine sample up to
340 Wl total volume. In order to control the sample pH to a narrow
range, sodium phosphate bu¡er (140 Wl, 100 mM in D2O, pD 7.4) was
added to the urine samples. The di¡erential dilution of the urine
samples with D2O to make the samples to comparable volumes
does not a¡ect the PR analysis because of the normalisation proce-
dure used during data processing and ensured that the phosphate
bu¡er concentration added remained consistent throughout the sam-
ple set. Trimethylsilylpropionic acid (50 Wl, 0.05 mg/ml in D2O) was
added as an internal reference standard. Samples were prepared and
analysed in a random order. 1H NMR spectra were acquired at 300 K
on a Bruker DRX-600 spectrometer as previously reported [4].
2.3. Data reduction of the NMR spectra
Data reduction and normalisation procedures were followed as pre-
viously reported [4].
2.4. Principal components analysis (PCA) of the 1H NMR spectral
data
The normalised, centred data were analysed by PCA to establish
any ‘groupings’ with respect to strain or diurnal cycles. A PCA model
was constructed using all samples. The Scores plot of PC1 versus PC2
was examined for separation or clusters relating to the two strains of
mice, C57BL10J and Alpk:ApfCD, and variation related to diurnal
di¡erences between the AM and PM urine collections.
2.5. Prediction of classes by partial least squares-discriminant analysis
(PLS-DA)
As PCA indicated the presence of strain and diurnal-related sepa-
ration, data were analysed by PLS-DA with a view to establishing
whether the separation between the C57BL10J and Alpk:ApfCD AM
and PM clusters was signi¢cant by prediction of class.
PLS-DA models were constructed to establish the signi¢cance of
the e¡ects of strain and diurnal cycles on the urinary metabolite
pro¢les. Thus, to investigate the signi¢cance of strain-related variation
two PLS-DA model types were calculated, the ¢rst (PLS-DA model
type 1) related to strain di¡erences in the AM urine collections
(C57BL10J, AM=class 1 and Alpk:ApfCD, AM=class 2) and the
second (PLS-DA model type 2) included data relating to PM collec-
tions (C57BL10J, PM=class 1 and Alpk:ApfCD, PM=class 2). For
the purpose of cross-validation and due to the small number of sam-
ples, 10 validation PLS-DA models were calculated (¢ve for model
type 1 and ¢ve for model type 2) excluding 10% of the samples per
class in each validation model. To establish whether the di¡erences
were signi¢cant between strains the PLS-DA validation models were
used to predict the strain of the test samples. Class membership was
predicted using a value of 0.5 dividing line between the two classes
including values predicted using a class membership probability value
s 0.01.
The same procedure was applied to establish the signi¢cance of the
e¡ects of diurnal cycles on the urinary metabolite pro¢les, i.e. two
PLS-DA model types were calculated to investigate the di¡erences due
to diurnal cycles. The ¢rst (PLS-DA model type 3) investigated diur-
nal variation in the C57BL10J strain (C57BL10J, AM=class 1 and
C57BL10J, PM=class 2) and the second (PLS-DA model type 4)
investigated diurnal variation in the Alpk:ApfCD strain (Alpk:
ApfCD, AM=class 1 and Alpk:ApfCD, PM=class 2). These PLS-
DA models were validated as detailed for the investigation between
strains.
2.6. Application of OSC to remove diurnal- and strain-related
variations from 1H NMR spectral data
To remove and characterise the variation in metabolite pro¢les
caused by diurnal cycles, OSC, a spectral ¢ltering method, was ap-
plied to the NMR data. In the OSC procedure, the identity of the
sample classes is included in the calculation and assigned by a vector,
Y. The ¢rst step in the OSC procedure calculates the ¢rst principal
component, or score vector t, that is an optimal linear description of
the spectral data and describes maximum separation based on class.
The longest vector orthogonal to Y is calculated and this vector, t*,
describes the greatest source of variation that is not related to class
yet still provides a good summary of the spectral data [10]. This is
done as:
t ¼ ð13YðY 0YÞ31Y 0Þt
After this step, the loading vector, p*, relating to this corrected
vector is calculated and the product of the orthogonal score and
loading vectors is subtracted from the spectral data. Examination of
the OSC scores, t* and loadings p* can be useful in determining the
source of the removed variation. The residual matrix represents the
¢ltered spectral data and is then used for calculation of PCA or PLS-
based models.
To remove diurnal variation from the urinary 1H NMR data by
OSC, and focus subsequent analysis on the strain-related metabolic
di¡erences, observations relating the Alpk:ApfCD strain were speci-
¢ed as class 1 and the C57BL10J strain as class 2.
To illustrate how OSC can be utilised to selectively remove un-
wanted non-correlated variation from spectral data, the variation re-
lating to strain-related metabolic di¡erences was removed by applica-
tion of OSC. The observations relating to the AM urine collections
were speci¢ed as class 1 and the PM urine collections as class 2. The
OSC scores, t*, and loadings, p*, from both ¢ltering investigations
were examined to investigate the variation removed. The strategy used
for the OSC application in this study is shown in Fig. 1.
2.7. PCA of the OSC-¢ltered 1H NMR data
PCA was applied to both OSC-¢ltered NMR data sets. The scores
plots of PC1 versus PC2 were examined for separation between the
two strains of mice or between the diurnal groups. The corresponding
loadings were investigated to establish which NMR spectral regions
related to diurnal or strain-related metabolic di¡erences. The OSC
scores, t*, and loadings were also examined to characterise the varia-
tion removed from the ¢ltered data.
2.8. Prediction of classes by PLS-DA after application of OSC
To ascertain the validity of the separation between classes in the
PCA models calculated after application of OSC, prediction of classes
was repeated to (a) investigate the signi¢cance of the di¡erences be-
tween strains (class 1=Alpk:ApfCD, AM and PM, class 2=
C57BL10J, AM and PM) and (b) investigate the signi¢cance of
strain-related di¡erences (class 1 =AM observations and class 2=
PM observations).
Due to the small number of samples and as data relating to both
AM and PM observations were included in the PLS-DA models after
OSC (n=70), ¢ve PLS-DA validation models were calculated exclud-
ing representative samples from the Alpk:ApfCD, AM; Alpk:
ApfCD, PM; C57BL10J, AM and C57BL10J, PM classes. Samples
to be excluded from a PLS-DA model, calculated for the purpose of
prediction of class identity, were also excluded during the OSC pro-
cedure performed prior to PLS-DA. Excluded sample numbers ac-
counted for 10% of the total sample number for class prediction.
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3. Results
3.1. 1H NMR spectroscopy of urine samples from C57BL10J
and Alpk:ApfCD mice at AM and PM time-points
Visual inspection of the 1H NMR urine spectra revealed
changes in the patterns associated with a variety of di¡erences
between the two strains and diurnal variation (Fig. 2). Inter-
animal variation in urine composition and the complexity of
the spectra, coupled with di¡erences in the volume of urine
excreted, makes visual comparison of spectra di⁄cult, hence
chemometric methods of spectral analysis were employed.
3.2. PCA of 1H NMR urinary data
The scores plot of PC1 versus PC2 (Fig. 3) showed separa-
tion between the C57BL10J and Alpk:ApfCD strains. Dis-
tinct separation of the Alpk:ApfCD, AM cluster from both
the AM and PM C57BL10J cluster occurred in PC1.
Although PC2 described variation relating to the spectral dif-
ferences between the Alpk:ApfCD, PM cluster with both AM
and PM C57BL10J classes this separation was less distinct
and the C57BL10J AM cluster was only partially separated
from the Alpk:ApfCD PM cluster. Separation of the
C57BL10J AM and PM groups appeared to be partially sep-
arated in PC2 and formed a tighter cluster than the two Alp-
k:ApfCD clusters.
3.3. Investigation of the diurnal- and strain-related variations
by PLS-DA
PLS-DA was applied to these data to investigate whether
the C57BL10J and Alpk:ApfCD strains showed signi¢cantly
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Fig. 1. Strategy for demonstrating the application of OSC to 1H
NMR spectral data for the selective removal of confounding varia-
tion. 1) OSC was applied to remove confounding orthogonal varia-
tion from the 1H NMR urinary spectral data relating to the Alp-
k:ApfCD and C57BL10J mice. To remove diurnal variation, class
1=Alpk:ApfCD and class 2=C57BL10J. To remove strain-related
variation, class 1=AM and class 2 =PM urine collections. 2) The
OSC-¢ltered NMR data matrix was subsequently used for PCA in-
vestigations of (a) strain-related di¡erences between the Alp-
k:ApfCD and C57BL10J mice and (b) the e¡ects of diurnal cycles
on the urinary metabolite pro¢les in both mouse strains. Examina-
tion of the OSC scores, t*, and loadings, p*, enabled interpretation
of the variation removed by the OSC procedure. These corre-
sponded to t* and p* relating to (a) removed diurnal variation and
(b) removed strain-related variation.
Fig. 2. 600 MHz 1H NMR spectra of representative Alpk:ApfCD
and C57BL10J mouse urine collected at AM and PM time-points.
Key: (a) C57BL10J AM; (b) C57BL10J PM; (c) Alpk:ApfCD AM;
(d) Alpk:ApfCD PM; A=acetate; B= acetamide; C= citrate;
D= creatine; E= creatinine; F=dimethylamine; G=guanodinoacetic
acid; H=hippurate; I = 3-hydroxy-iso-valerate; J =methylamine;
K=N-acetyl glycoproteine; L= 2-oxo-glutarate; M= spermine;
N= succinate; O= trimethylamine; P= trimethylamine-N-oxide;
Q= taurine.
Table 1
Summary of prediction results investigating the diurnal e¡ects in two strains of mice by PLS-DA
PLS-DA model Percentage of correct predicted
classi¢cations
Percentage of predictions correct with
signi¢cance6 0.01
C57BL10J, AM versus Alpk:ApfCD, AM 100 90
C57BL10J, PM versus Alpk:ApfCD, PM 100 90
C57BL10J, AM versus C57BL10J, PM 100 100
Alpk:ApfCD, AM versus Alpk:ApfCD, PM 100 80
The prediction results are an average of ten test samples calculated from predictions of ¢ve validation models per PLS-DA model stated. Two
test samples were used per PLS-DA model for prediction of class membership.
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els were calculated to (a) investigate the signi¢cance of the
di¡erences between the strains at each time-point and (b) in-
vestigate the signi¢cance of the diurnal e¡ects in each strain.
The prediction results (Table 1) show that for one-component
models, the di¡erences between the Alpk:ApfCD and
C57BL10J strains, at both AM and PM time-points, can be
predicted accurately in 100% of cases and predicted 90% ac-
curately with signi¢cance 9 0.01. The di¡erences between the
diurnal cycles in each strain of mouse are predicted accurately
in 100% of cases and predicted v 80% accurately with signi¢-
cance 9 0.01.
3.4. OSC-PCA application to 1H NMR urinary data to remove
diurnal- and strain-related variation
The 1H NMR urinary data were ¢ltered using OSC to re-
move (a) diurnal- and (b) strain-related variation. Following
OSC, PCA models were calculated to examine variation relat-
ing to (a) strain di¡erences and (b) diurnal cycles (Fig. 1).
Resultant scores plots of PC1 versus PC2 (Fig. 4(1)) showed
distinct separation in PC1 between (a) C57BL10J and Alp-
k:ApfCD strains and (b) AM and PM observations, respec-
tively. All PCA components were examined and con¢rmed
that (a) diurnal- and (b) strain-related separations were e¡ec-
tively removed during the OSC procedure for both investiga-
tions.
The OSC scores, t*, and loadings, p*, were examined in
both analyses to investigate the variation removed during
the OSC procedure. The OSC scores, t*, obtained for the
OSC-PCA investigation of strain-related di¡erences (Fig.
4(2a)) showed distinct separation between the Alpk:ApfCD,
AM and Alpk:ApfCD, PM observations and apparent partial
separation between the C57BL10J, AM and C57BL10J, PM
observations, re£ective of the diurnal-related separation ob-
served in the scores plots from PCA prior to OSC (Fig. 3).
Examination of the OSC loadings (Fig. 5) revealed the di¡er-
ences in the spectral regions describing diurnal-related varia-
tion.
The OSC scores, t*, obtained for the OSC-PCA investiga-
tion of diurnal-related di¡erences (Fig. 4(2b)) showed partial
separation between the Alpk:ApfCD and C57BL10J strains,
indicating that strain-related variation had been e¡ectively
¢ltered from the spectral data. Examination of the OSC load-
ings and interpretation of the respective metabolite changes
associated with the strain-related separation observed in the
OSC scores con¢rmed that strain-related variation had been
removed.
As pre-¢ltering the data by OSC is a PLS-based supervised
method, the interpretation of the PCA models investigating
strain- and diurnal-related variations were validated by pre-
diction of class using PLS-DA. The prediction results (Table
2) for one-component models predicted v 95% correctly for
the strain or diurnal cycle with signi¢cance 9 0.01.
Fig. 3. PC scores plot derived from the 1H NMR spectra of urine
samples obtained from Alpk:ApfCD and C57BL10J mice collected
at AM and PM time-points. Key: a=Alpk:ApfCD, AM; b=Alpk:
ApfCD, PM; EC57BL10J, AM; F=C57BL10J, PM.
Fig. 4. Scores plots generated from application of OSC to remove
(a) diurnal-related variation and (b) strain-related variation. (1) PC
scores plot from the 1H NMR spectra of urine samples obtained
from Alpk:ApfCD and C57BL10J mice after application of OSC.
Key: a=Alpk:ApfCD, AM; b=Alpk:ApfCD, PM; E=C57BL10J,
AM; F=C57BL10J, PM. (2) Plot of OSC scores relating to the
variation removed by OSC. Key: OA=Alpk:ApfCD, AM; RA=
Alpk:ApfCD, PM; OC=C57BL10J, AM; RC=C57BL10J, PM.
Table 2
Summary of PLS-DA prediction results investigating biochemical changes associated with diurnal cycles and strain di¡erences
PLS-DA class prediction Percentage of correct
predicted classi¢cations
Percentage of predictions correct with
signi¢cance6 0.01
Prediction of strain 100 95
Prediction of diurnal cycle 100 100
For each class the percentage reported is an average obtained from ¢ve training PLS-DA models. These were calculated after an OSC proce-
dure removing either variation relating to diurnal cycles or strain di¡erences.
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4. Discussion
4.1. Diurnal variation in the biochemical composition of urine
We have shown that there is marked diurnal variation in
metabolite excretion pro¢les both in Alpk:ApfCD and
C57BL10J mice. PCA revealed that such variation appeared
greater in the Alpk:ApfCD strain compared to the C57BL10J
strain as indicated by the tighter clustering of the individuals
and partial overlap of the AM and PM observations in the
C57BL10J strain. Prediction of class by PLS-DA established
that the separation observed in the scores plots from PCA
(Fig. 2) was due to signi¢cant diurnal-related variation in
the urinary 1H NMR metabolite pro¢les in both mouse
strains. Further interpretation of the PCA model to establish
the metabolic di¡erences between the two mouse strains was
confounded by the in£uence of diurnal variation, illustrating
how normal physiological variation factors may hinder me-
tabonomic analyses. It is axiomatic that gene expression and
protein synthesis must also be a¡ected by such normal phys-
iological variation and hence we can infer that interpretation
of genomic and proteomic data may bene¢t from OSC treat-
ment. By removing confounding variation from these data
sets interpretation would be focused to the disease model or
toxicity e¡ect under investigation.
OSC was applied to the NMR spectral data to remove the
in£uence of diurnal metabolic perturbations and examination
of the OSC scores (Fig. 4(2a)) showed separation between the
Alpk:ApfCD diurnal groups and apparent partial separation
of the C57BL10J diurnal groups, con¢rming that the variation
removed during OSC related to diurnal cycles. Furthermore,
the separation between the Alpk:ApfCD and C57BL10J diur-
nal groups re£ected that observed in the PCA scores plot (Fig.
3) prior to OSC. Thus, the Alpk:ApfCD diurnal groups were
distinctly separated in the OSC scores plot whereas the
C57BL10J diurnal groups showed partial overlap. Examina-
tion of the OSC loadings revealed the spectral regions respon-
sible for the di¡erences in metabolite pro¢les caused by diur-
nal variation in the Alpk:ApfCD and C57BL10J mouse
strains and the relative metabolite changes contained within
these spectral regions for AM and PM urinary pro¢les were
identi¢ed (Fig. 5). The AM samples contained relatively high-
er levels of tricarboxylic acid cycle intermediates (citrate and
2-oxo-glutarate), indicating that the metabolite pro¢le di¡er-
ences re£ected the increased metabolic activity of mice during
the night.
Following the OSC procedure removing diurnal-related var-
iation, PCA resulted in distinct strain-related separation of the
C57BL10J and Alpk:ApfCD groups in PC1, and the scores
plot of PC1 versus PC2 (Fig. 4(1a)) indicated that diurnal-
related variation had been removed. The PC1 loadings and
corresponding urinary metabolic di¡erences between the
strains were examined and the results were compared to pre-
vious work investigating strain di¡erences between male
C57B10J and Alpk:ApfCD strains [4]. Generally, the strain-
related metabolic di¡erences concurred with previously re-
ported results. The Alpk:ApfCD mice contained relatively
higher levels of creatine and lower levels of guanidinoacetic
acid, supporting the previously reported suggestion that gua-
nidinoacetate methyltransferase-dependent pathways are more
active in the Alpk:ApfCD mice. However, although the levels
of trimethylamine-N-oxide (TMAO) were still relatively high-
er in the Alpk:ApfCD mice compared to the C57BL10J mice,
in the present study the range of TMAO concentrations
present in the Alpk:ApfCD varied greatly and in some cases,
the urinary TMAO levels were similar to those in the
C57BL10J group. In the previous study, TMAO concentra-
tions were signi¢cantly higher in the Alpk:ApfCD mice [4].
The ratio of trimethylamine (TMA) concentrations was still
an important discriminating factor between the strains in the
present study but this ratio was inverse to earlier ¢ndings,
thus the Alpk:ApfCD mice contained higher levels of TMA
than the C57BL10J mice. The TMA:TMAO ratios in the
C57BL10J mice were comparable in both previous and
present studies [4]. TMA concentrations were consistently
higher relative to TMAO concentrations in both studies.
Urinary TMA levels are known to originate from the action
of intestinal micro£ora on precursors such as choline [15,16].
Studies have shown that animal handling can a¡ect colon
temperature and this is referred to as stress-induced hypother-
mia (SIH) [17]. There is the possiblity that the animals from
this study may have experienced SIH. However, from prelimi-
nary studies (data not shown), where urine was collected from
mice in the afternoon, and therefore not exposed to any stress
from handling prior to urine collection, we observed di¡er-
ences in the urinary composition compared to AM urine col-
lections obtained from di¡erent animals. As the animals used
in this study were from colonies which are handled regularly
and have been maintained since 1967, we previously proposed
that it would be unlikely that the observed changes in
TMA:TMAO ratios were due to a systematic di¡erence in
gut micro£oral activity [4]. However, a recently reported study
by Gareipy et al. investigated di¡erences in adult stress regu-
lation between highly aggressive and non-aggressive mice and
they showed that the systemic e¡ects of handling are modu-
lated by genetic background [18]. These ¢ndings indicate that
the C57BL10J and Alpk:ApfCD strains may experience dif-
ferent levels of stress upon handling and hence exhibit di¡er-
ent SIH responses. Thus, we cannot exclude the possibility
that handling has a minor e¡ect on metabolism, in particular
Fig. 5. Plot of OSC loadings showing NMR spectral descriptors re-
lating to diurnal variation removed during OSC procedure. Each
bar represents a spectral region covering 0.04 ppm. This plot shows
how the 1H NMR metabolite pro¢les of the AM and PM urine
samples di¡er, where a positive value indicates that relatively greater
urinary concentration of a metabolite is present in the AM sample.
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metabolism of the methylamines by the gut micro£ora, and on
the urinary metabolite pro¢les obtained. The scores obtained
from PC models constructed prior to and post application of
OSC and the OSC scores t* generated were examined for any
separation indicative of a SIH response. No trend or separa-
tion according to the order of urine collections was observed
in the AM and PM urine collections in both strains. Thus, we
conclude that stress e¡ects resulting from the animal handling
procedure the animals in the current study were exposed to
were minimal and the separation between the AM and PM
urine collections is attributed to genuine diurnal metabolic
regulation. However, the work by Gareipy et al. does indicate
that the systemic e¡ects of animal handling should be consid-
ered in all studies where metabonomic, proteomic and ge-
nomic data are used.
The present study indicates that the urinary products from
the methylamine pathway are strongly in£uenced by diurnal
cycles and that the in£uence of diurnal cycles is more pro-
nounced in the Alpk:ApfCD strain. The urine collections in
these studies do not contain time-averaging e¡ects that are
observed when urine is collected over de¢ned time periods
from animals placed in metabolic cages, as typi¢ed in metabo-
nomic studies in rat models. In this study urine was collected
at a ¢xed time interval for each animal by manipulation of the
lower abdomen, thus enhancing the sensitivity of the metabo-
nomic analysis to the in£uence of diurnal cycles. This in-
creased sensitivity is also an important consideration for the
application of metabonomic studies in humans, as bio£uid
measurements (e.g. plasma, sera) are at ¢xed time intervals
and are representative of the metabolite ‘¢ngerprint’ at the
time of sampling.
We have shown in this study the confounding in£uence of
diurnal cycles in the urinary metabolite pro¢les in the Alp-
k:ApfCD and C57BL10J mouse strains and how the Alp-
k:ApfCD urinary metabolite pro¢les were more in£uenced
by diurnal cycles. Application of OSC to NMR spectral
data demonstrated how this approach can selectively remove
confounding variation in metabonomic studies, focusing inter-
pretation of metabolite excretion pro¢les to strain-related dif-
ferences between the phenotypically normal Alpk:ApfCD and
C57BL10J mouse strains. The potential for metabotyping
mice using NMR of bio£uids in the evaluation of animal
models of disease and drug e⁄cacy has been proposed in
earlier work [4]. We have shown here that OSC improves
the e¡ectiveness of the use of metabonomics in functional
genomic studies and for minimising confounding variation
with signi¢cant exogenous components and in£uences.
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